UroGen Pharma Future Growth

How is UroGen Pharma forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

56.1%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:URGN - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	248	19	53	N/A	2
12/31/2024	132	-55	-11	N/A	4
12/31/2023	91	-88	-57	N/A	6
9/30/2022	62	-109	-86	-86	N/A
6/30/2022	58	-114	-87	-87	N/A
3/31/2022	54	-113	-82	-81	N/A
12/31/2021	48	-111	-86	-85	N/A
9/30/2021	40	-113	-87	-86	N/A
6/30/2021	32	-111	-94	-93	N/A
3/31/2021	19	-117	-99	-98	N/A
12/31/2020	12	-128	-107	-106	N/A
9/30/2020	4	-137	-112	-111	N/A
6/30/2020	0	-130	-99	-98	N/A
3/31/2020	0	-121	-89	-89	N/A
12/31/2019	0	-105	-71	-71	N/A
9/30/2019	0	-90	-55	-55	N/A
6/30/2019	0	-88	-52	-52	N/A
3/31/2019	1	-84	-46	-46	N/A
12/31/2018	1	-76	-38	-37	N/A
9/30/2018	1	-62	-34	-33	N/A
6/30/2018	9	-42	-22	-21	N/A
3/31/2018	9	-30	-17	-16	N/A
12/31/2017	8	-21	-10	-10	N/A
9/30/2017	25	2	10	10	N/A
6/30/2017	18	-7	3	4	N/A
3/31/2017	18	-4	3	4	N/A
12/31/2016	18	-4	3	4	N/A
9/30/2016	N/A	-24	-11	-11	N/A

Earnings vs Savings Rate: URGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: URGN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: URGN is expected to become profitable in the next 3 years.

Revenue vs Market: URGN's revenue (36% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: URGN's revenue (36% per year) is forecast to grow faster than 20% per year.

Future ROE: Insufficient data to determine if URGN's Return on Equity is forecast to be high in 3 years time